The Association Between Different Obesity Phenotypes and Liver Fibrosis Scores in Elderly Individuals with Fatty Liver in Taiwan

References

• Seto WK , Yuen MF . Nonalcoholic fatty liver disease in Asia: emerging perspectives. J Gastroenterol . 2017;52(2):164–174. doi:10.1007/s00535-016-1264-3 27637587
   PubMed Web of Science ®Google Scholar
• Chen CH , Huang MH , Yang JC , et al. Prevalence and risk factors of nonalcoholic fatty liver disease in an adult population of Taiwan: metabolic significance of nonalcoholic fatty liver disease in nonobese adults. J Clin Gastroenterol . 2006;40(8):745–752. doi:10.1097/00004836-200609000-00016 16940890
   PubMed Web of Science ®Google Scholar
• Lin TJ , Lin CL , Wang CS , Liu SO , Liao LY . Prevalence of HFE mutations and relation to serum iron status in patients with chronic hepatitis C and patients with nonalcoholic fatty liver disease in Taiwan. World J Gastroenterol . 2005;11(25):3905. doi:10.3748/wjg.v11.i25.3905 15991291
   PubMed Web of Science ®Google Scholar
• Hung SC , Lai SW , Chen MC , Li PC , Lin KC . Prevalence and related factors of non-alcoholic fatty liver disease among the elderly in Taiwan. Eur Geriatr Med . 2013;4(2):78–81. doi:10.1016/j.eurger.2012.11.004
   Web of Science ®Google Scholar
• Kojima S , Watanabe N , Numata M , Ogawa T , Matsuzaki S . Increase in the prevalence of fatty liver in Japan over the past 12 years: analysis of clinical background. J Gastroenterol . 2003;38(10):954–961. doi:10.1007/s00535-003-1178-8 14614602
   PubMed Web of Science ®Google Scholar
• McPherson S , Hardy T , Henderson E , Burt AD , Day CP , Anstee QM . Evidence of NAFLD progression from steatosis to fibrosing-steatohepatitis using paired biopsies: implications for prognosis and clinical management. J Hepatol . 2015;62(5):1148–1155. doi:10.1016/j.jhep.2014.11.034 25477264
   PubMed Web of Science ®Google Scholar
• Singh S , Allen AM , Wang Z , Prokop LJ , Murad MH , Loomba R . Fibrosis progression in nonalcoholic fatty liver vs nonalcoholic steatohepatitis: a systematic review and meta-analysis of paired-biopsy studies. Clin Gastroenterol Hepatol . 2015;13(4):643–654. doi:10.1016/j.cgh.2014.04.014 24768810
   PubMed Web of Science ®Google Scholar
• Argo CK , Northup PG , Al-Osaimi AM , Caldwell SH . Systematic review of risk factors for fibrosis progression in non-alcoholic steatohepatitis. J Hepatol . 2009;51(2):371–379. doi:10.1016/j.jhep.2009.03.019 19501928
   PubMed Web of Science ®Google Scholar
• Lonardo A , Byrne CD , Caldwell SH , Cortez-Pinto H , Targher G . Global epidemiology of nonalcoholic fatty liver disease: meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology . 2016;64(4):1388–1389. doi:10.1002/hep.28584 27038241
   PubMed Web of Science ®Google Scholar
• Kumar R , Priyadarshi RN , Anand U . Non-alcoholic fatty liver disease: growing burden, adverse outcomes and associations. J Clin Transl Hepatol . 2020;8(1):76–86. doi:10.14218/JCTH.2019.00051 32274348
   PubMed Web of Science ®Google Scholar
• Said A , Ghufran A . Epidemic of non-alcoholic fatty liver disease and hepatocellular carcinoma. World J Clin Oncol . 2017;8(6):429–436. doi:10.5306/wjco.v8.i6.429 29291167
   PubMed Web of Science ®Google Scholar
• Ekstedt M , Hagstrom H , Nasr P , et al. Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up. Hepatology . 2015;61(5):1547–1554. doi:10.1002/hep.27368 25125077
   PubMed Web of Science ®Google Scholar
• Angulo P , Kleiner DE , Dam-Larsen S , et al. Liver fibrosis, but no other histologic features, is associated with long-term outcomes of patients with nonalcoholic fatty liver disease. Gastroenterology . 2015;149(2):389–397e310. doi:10.1053/j.gastro.2015.04.043 25935633
   PubMed Web of Science ®Google Scholar
• Shah AG , Lydecker A , Murray K , et al. Comparison of noninvasive markers of fibrosis in patients with nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol . 2009;7(10):1104–1112. doi:10.1016/j.cgh.2009.05.033 19523535
   PubMed Web of Science ®Google Scholar
• Angulo P , Hui JM , Marchesini G , et al. The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD. Hepatology . 2007;45(4):846–854. doi:10.1002/hep.21496 17393509
   PubMed Web of Science ®Google Scholar
• Sterling RK , Lissen E , Clumeck N , et al. Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection. Hepatology . 2006;43(6):1317–1325. doi:10.1002/hep.21178 16729309
   PubMed Web of Science ®Google Scholar
• Subasi CF , Aykut UE , Yilmaz Y . Comparison of noninvasive scores for the detection of advanced fibrosis in patients with nonalcoholic fatty liver disease. Eur J Gastroenterol Hepatol . 2015;27(2):137–141. doi:10.1097/MEG.0000000000000255 25486027
   PubMed Web of Science ®Google Scholar
• Mishra A , Younossi ZM . Epidemiology and natural history of non-alcoholic fatty liver disease. J Clin Exp Hepatol . 2012;2(2):135–144. doi:10.1016/S0973-6883(12)60102-9 25755422
   PubMedGoogle Scholar
• Fan JG , Saibara T , Chitturi S , et al. What are the risk factors and settings for non-alcoholic fatty liver disease in Asia-Pacific? J Gastroenterol Hepatol . 2007;22(6):794–800. doi:10.1111/j.1440-1746.2007.04952.x 17498218
   PubMed Web of Science ®Google Scholar
• Fan JG , Zhu J , Li XJ , et al. Fatty liver and the metabolic syndrome among Shanghai adults. J Gastroenterol Hepatol . 2005;20(12):1825–1832. doi:10.1111/j.1440-1746.2005.04058.x 16336439
   PubMed Web of Science ®Google Scholar
• Lonardo A , Mantovani A , Lugari S , Targher G . Epidemiology and pathophysiology of the association between NAFLD and metabolically healthy or metabolically unhealthy obesity. Ann Hepatol . 2020;19(4):359–366. doi:10.1016/j.aohep.2020.03.001 32349939
   PubMed Web of Science ®Google Scholar
• Ampuero J , Aller R , Gallego-Duran R , et al. The effects of metabolic status on non-alcoholic fatty liver disease-related outcomes, beyond the presence of obesity. Aliment Pharmacol Ther . 2018;48(11–12):1260–1270. doi:10.1111/apt.15015 30353552
   PubMed Web of Science ®Google Scholar
• Petta S , Eslam M , Valenti L , et al. Metabolic syndrome and severity of fibrosis in nonalcoholic fatty liver disease: an age-dependent risk profiling study. Liver Int . 2017;37(9):1389–1396. doi:10.1111/liv.13397 28235154
   PubMed Web of Science ®Google Scholar
• Lonardo A , Nascimbeni F , Mantovani A , Targher G . Hypertension, diabetes, atherosclerosis and NASH: cause or consequence? J Hepatol . 2018;68(2):335–352. doi:10.1016/j.jhep.2017.09.021 29122390
   PubMed Web of Science ®Google Scholar
• Chen SC , Tsai SP , Jhao JY , Jiang WK , Tsao CK , Chang LY . Liver fat, hepatic enzymes, alkaline phosphatase and the risk of incident type 2 diabetes: a prospective study of 132,377 adults. Sci Rep . 2017;7(1):4649. doi:10.1038/s41598-017-04631-7 28680048
   PubMed Web of Science ®Google Scholar
• Sung KC , Wild SH , Byrne CD . Development of new fatty liver, or resolution of existing fatty liver, over five years of follow-up, and risk of incident hypertension. J Hepatol . 2014;60(5):1040–1045. doi:10.1016/j.jhep.2014.01.009 24445219
   PubMed Web of Science ®Google Scholar
• Frith J , Day CP , Henderson E , Burt AD , Newton JL . Non-alcoholic fatty liver disease in older people. Gerontology . 2009;55(6):607–613. doi:10.1159/000235677 19690397
   PubMed Web of Science ®Google Scholar
• Miyaaki H , Ichikawa T , Nakao K , et al. Clinicopathological study of nonalcoholic fatty liver disease in Japan: the risk factors for fibrosis. Liver Int . 2008;28(4):519–524. doi:10.1111/j.1478-3231.2007.01614.x 17976158
   PubMed Web of Science ®Google Scholar
• Lonardo A , Nascimbeni F , Ballestri S , et al. Sex differences in nonalcoholic fatty liver disease: state of the art and identification of research gaps. Hepatology . 2019;70(4):1457–1469. doi:10.1002/hep.30626 30924946
   PubMed Web of Science ®Google Scholar
• Friedewald WT , Levy RI , Fredrickson DS . Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin chem . 1972;18(6):499–502. doi:10.1093/clinchem/18.6.499 4337382
   PubMed Web of Science ®Google Scholar
• Martin SS , Blaha MJ , Elshazly MB , et al. Comparison of a novel method vs the Friedewald equation for estimating low-density lipoprotein cholesterol levels from the standard lipid profile. JAMA . 2013;310(19):2061–2068. doi:10.1001/jama.2013.280532 24240933
   PubMed Web of Science ®Google Scholar
• Hernaez R , Lazo M , Bonekamp S , et al. Diagnostic accuracy and reliability of ultrasonography for the detection of fatty liver: a meta-analysis. Hepatology . 2011;54(3):1082–1090. doi:10.1002/hep.24452 21618575
   PubMed Web of Science ®Google Scholar
• Pan WH , Flegal KM , Chang HY , Yeh WT , Yeh CJ , Lee WC . Body mass index and obesity-related metabolic disorders in Taiwanese and US whites and blacks: implications for definitions of overweight and obesity for Asians. Am J Clin Nutr . 2004;79(1):31–39. doi:10.1093/ajcn/79.1.31 14684394
   PubMed Web of Science ®Google Scholar
• Chen HY , Lu FH , Chang CJ , et al. Metabolic abnormalities, but not obesity per se, associated with chronic kidney disease in a Taiwanese population. Nutr Metab Cardiovasc Dis . 2020;30(3):418–425. doi:10.1016/j.numecd.2019.09.029 31744713
   PubMed Web of Science ®Google Scholar
• Eftekharzadeh A , Asghari G , Serahati S , et al. Predictors of incident obesity phenotype in nonobese healthy adults. Eur J Clin Invest . 2017;47(5):357–365. doi:10.1111/eci.12743 28294315
   PubMed Web of Science ®Google Scholar
• McPherson S , Hardy T , Dufour JF , et al. Age as a confounding factor for the accurate non-invasive diagnosis of advanced NAFLD fibrosis. Am J Gastroenterol . 2017;112(5):740–751. doi:10.1038/ajg.2016.453 27725647
   PubMed Web of Science ®Google Scholar
• Chang Y , Jung HS , Cho J , et al. Metabolically healthy obesity and the development of nonalcoholic fatty liver disease. Am J Gastroenterol . 2016;111(8):1133–1140. doi:10.1038/ajg.2016.178 27185080
   PubMed Web of Science ®Google Scholar
• Kim Y , Chang Y , Cho YK , Ahn J , Shin H , Ryu S . Metabolically healthy versus unhealthy obesity and risk of fibrosis progression in non-alcoholic fatty liver disease. Liver Int . 2019;39(10):1884–1894. doi:10.1111/liv.14184 31226232
   PubMed Web of Science ®Google Scholar
• Heianza Y , Arase Y , Tsuji H , et al. Metabolically healthy obesity, presence or absence of fatty liver, and risk of type 2 diabetes in Japanese individuals: Toranomon hospital health management center study 20 (TOPICS 20). J Clin Endocrinol Metab . 2014;99(8):2952–2960. doi:10.1210/jc.2013-4427 24823457
   PubMed Web of Science ®Google Scholar
• Chen TP , Lai M , Lin WY , Huang KC , Yang KC . Metabolic profiles and fibrosis of nonalcoholic fatty liver disease in the elderly: a community-based study. J Gastroenterol Hepatol . 2020;35(9):1636–1643. doi:10.1111/jgh.15073 32333452
   PubMed Web of Science ®Google Scholar
• Gutierrez-Grobe Y , Juarez-Hernandez E , Sanchez-Jimenez BA , et al. Less liver fibrosis in metabolically healthy compared with metabolically unhealthy obese patients with non-alcoholic fatty liver disease. Diabetes Metab . 2017;43(4):332–337. doi:10.1016/j.diabet.2017.02.007 28318912
   PubMed Web of Science ®Google Scholar
• Ballestri S , Nascimbeni F , Baldelli E , Marrazzo A , Romagnoli D , Lonardo A . NAFLD as a sexual dimorphic disease: role of gender and reproductive status in the development and progression of nonalcoholic fatty liver disease and inherent cardiovascular risk. Adv Ther . 2017;34(6):1291–1326. doi:10.1007/s12325-017-0556-1 28526997
   PubMed Web of Science ®Google Scholar
• Ishiba H , Sumida Y , Tanaka S , et al. The novel cutoff points for the FIB4 index categorized by age increase the diagnostic accuracy in NAFLD: a multi-center study. J Gastroenterol . 2018;53(11):1216–1224. doi:10.1007/s00535-018-1474-y 29744597
   PubMed Web of Science ®Google Scholar
• Patel YA , Gifford EJ , Glass LM , et al. Identifying nonalcoholic fatty liver disease advanced fibrosis in the veterans health administration. Dig Dis Sci . 2018;63(9):2259–2266. doi:10.1007/s10620-018-5123-3 29779083
   PubMed Web of Science ®Google Scholar
• Hamaguchi M , Kojima T , Takeda N , et al. The metabolic syndrome as a predictor of nonalcoholic fatty liver disease. Ann Intern Med . 2005;143(10):722–728. doi:10.7326/0003-4819-143-10-200511150-00009 16287793
   PubMed Web of Science ®Google Scholar
• Lonardo A , Suzuki A . Sexual dimorphism of NAFLD in adults. Focus on clinical aspects and implications for practice and translational research. J Clin Med . 2020;9(5):1278. doi:10.3390/jcm9051278
   PubMed Web of Science ®Google Scholar
• Friedman SL , Neuschwander-Tetri BA , Rinella M , Sanyal AJ . Mechanisms of NAFLD development and therapeutic strategies. Nat Med . 2018;24(7):908–922. doi:10.1038/s41591-018-0104-9 29967350
   PubMed Web of Science ®Google Scholar
• Farrell GC , Larter CZ . Nonalcoholic fatty liver disease: from steatosis to cirrhosis. Hepatology . 2006;43(2 Suppl 1):S99–S112. doi:10.1002/hep.20973 16447287
   PubMed Web of Science ®Google Scholar
• Gan L , Chitturi S , Farrell GC . Mechanisms and implications of age-related changes in the liver: nonalcoholic Fatty liver disease in the elderly. Curr Gerontol Geriatr Res . 2011;2011:831536. doi:10.1155/2011/831536 21918648
   PubMedGoogle Scholar
• Gutierrez-Grobe Y , Ponciano-Rodríguez G , Ramos MH , Uribe M , Méndez-Sánchez N . Prevalence of non alcoholic fatty liver disease in premenopausal, posmenopausal and polycystic ovary syndrome women. The role of estrogens. Ann Hepatol . 2010;9(4):402–409. doi:10.1016/S1665-2681(19)31616-3 21057159
   PubMed Web of Science ®Google Scholar
• Della Torre S . Non-alcoholic fatty liver disease as a canonical example of metabolic inflammatory-based liver disease showing a sex-specific prevalence: relevance of estrogen signaling. Front Endocrinol (Lausanne) . 2020;11:572490.33071979
   PubMed Web of Science ®Google Scholar
• Karastergiou K , Smith SR , Greenberg AS , Fried SK . Sex differences in human adipose tissues - the biology of pear shape. Biol Sex Differ . 2012;3(1):13. doi:10.1186/2042-6410-3-13 22651247
   PubMed Web of Science ®Google Scholar
• Balakrishnan M , Patel P , Dunn-Valadez S , et al. Women have a lower risk of nonalcoholic fatty liver disease but a higher risk of progression vs men: a systematic review and meta-analysis. Clin Gastroenterol Hepatol . 2021;19(1):61–71e15. doi:10.1016/j.cgh.2020.04.067 32360810
   PubMed Web of Science ®Google Scholar
• Pitisuttithum P , Chan WK , Piyachaturawat P , et al. Predictors of advanced fibrosis in elderly patients with biopsy-confirmed nonalcoholic fatty liver disease: the GOASIA study. BMC Gastroenterol . 2020;20(1):88. doi:10.1186/s12876-020-01240-z 32252638
   PubMed Web of Science ®Google Scholar